Application of nanoparticle-based siRNA and CRISPR/Cas9 delivery systems in gene-targeted therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of nanoparticle-based siRNA and CRISPR/Cas9 delivery systems in gene-targeted therapy
Authors
Keywords
-
Journal
Nanomedicine
Volume 14, Issue 5, Pages 511-514
Publisher
Future Medicine Ltd
Online
2019-02-26
DOI
10.2217/nnm-2018-0522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles
- (2018) Ying-Li Luo et al. ACS Nano
- Molecular targeted therapy: treating cancer with specificity
- (2018) Yeuan Ting Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
- (2018) Hong-Xia Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineering the Delivery System for CRISPR-Based Genome Editing
- (2018) Zachary Glass et al. TRENDS IN BIOTECHNOLOGY
- Combination-Responsive MoO3–x-Hybridized Hyaluronic Acid Hollow Nanospheres for Cancer Phototheranostics
- (2018) Yuan-Yuan Wang et al. ACS Applied Materials & Interfaces
- Nano-based delivery of RNAi in cancer therapy
- (2017) Yong Xin et al. Molecular Cancer
- Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid via a Gold Nanocluster/Lipid Core-Shell Nanocarrier
- (2017) Peng Wang et al. Advanced Science
- Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
- (2017) Kunwoo Lee et al. Nature Biomedical Engineering
- Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice
- (2016) Ling Li et al. ACS Nano
- Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
- (2016) Susan Ashton et al. Science Translational Medicine
- Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing
- (2015) Wujin Sun et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
- (2015) Michael Boettcher et al. MOLECULAR CELL
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Biomaterials for mRNA delivery
- (2015) Mohammad Ariful Islam et al. Biomaterials Science
- Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo
- (2014) A. J. Iqbal et al. BLOOD
- First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors
- (2014) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Nanoparticle-Enabled, Image-Guided Treatment Planning of Target Specific RNAi Therapeutics in an Orthotopic Prostate Cancer Model
- (2014) Qiaoya Lin et al. Small
- Molecular imaging for cancer diagnosis and surgery
- (2013) Timon Hussain et al. ADVANCED DRUG DELIVERY REVIEWS
- Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System
- (2013) Baohui Chen et al. CELL
- Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system
- (2013) Albert W Cheng et al. CELL RESEARCH
- Multimodality Imaging of RNA Interference
- (2013) T. Nayak et al. CURRENT MEDICINAL CHEMISTRY
- A mesoporous silica nanoparticle – PEI – Fusogenic peptide system for siRNA delivery in cancer therapy
- (2012) Xu Li et al. BIOMATERIALS
- The Business of RNAi Therapeutics
- (2008) Dirk Haussecker HUMAN GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started